Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Christopher Porter to Neoplastic Stem Cells

This is a "connection" page, showing publications Christopher Porter has written about Neoplastic Stem Cells.

 
Connection Strength
 
 
 
0.300
 
  1. Zheng H, Zhao P, Tan Z, Yu WM, Werner J, Stieglitz E, Porter CC, Chandrakasan S, Wechsler DS, Mendez-Ferrer S, Qu CK. Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML. Cell Rep. 2025 Aug 26; 44(8):116087.
    View in: PubMed
    Score: 0.176
  2. Chen KZ, Kazi R, Porter CC, Qu CK. Germline mutations: many roles in leukemogenesis. Curr Opin Hematol. 2020 07; 27(4):288-293.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)